Skip to main content

Table 1 The relationship between clinical features and expression levels of miR-96 and FOXO1

From: miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma

Clinical features

n

Relative of miR-96 expression

t value

P value

Relative of FOXO1 expression

t value

P value

Lymph node metastasis

  

2.61

0.02

 

− 2.14

0.04

 Positive

11

2.45 ± 0.29

  

0.31 ± 0.13

  

 Negative

16

2.24 ± 0.12

  

0.44 ± 0.17

  

Infiltration

  

2.34

0.03

 

− 2.55

0.02

 Positive

13

2.53 ± 0.26

  

0.38 ± 0.11

  

 Negative

14

2.33 ± 0.18

  

0.51 ± 0.15

  

Differentiation

  

2.15

0.04

 

− 2.16

0.04

 Low-medium

19

2.38 ± 0.22

  

0.35 ± 0.12

  

 High

8

2.19 ± 0.18

  

0.48 ± 0.19

  
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us